SCHEMBL9993136

SCHEMBL9993136

CCN(C(=O)O)C1CC2(CCN(c3ccc(C=C(C)C)cn3)CC2)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.36
HPGD P15428 3/20 0.36
ALDH1A1 P00352 3/20 0.36
GPR119 Q8TDV5 1/20 0.35
DGAT1 O75907 9/20 0.35
KCNH2 Q12809 7/20 0.35
CYP2C9 P11712 3/20 0.35
CYP3A4 P08684 3/20 0.35
FFAR4 Q5NUL3 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
ACAT1 P24752 1/20 0.33
TSHR P16473 2/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
ME2 P23368 1/20 0.32
ME1 P48163 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3793052 0.89 HSD17B10 (0.37) HSD17B10HPGDALDH1A1GPR119DGAT1
SCHEMBL9994511 0.84 AKR1C3 (0.42) HSD17B10HPGDALDH1A1GPR119DGAT1
SCHEMBL3729566 0.81 RET (0.39) HSD17B10HPGDALDH1A1GPR119DGAT1
SCHEMBL346152 0.73 CKS1B (0.39) GPR119DGAT1KDM4ELMNA
SCHEMBL9994794 0.71 HRH3 (0.49) ALDH1A1DGAT1KCNH2FFAR4LMNA
SCHEMBL360587 0.67 FFAR4 (0.57) DGAT1KCNH2CYP2C9CYP3A4FFAR4
SCHEMBL2334744 0.67 CHRM4 (0.48) ALDH1A1SMN1; SMN2TSHRLMNARAB9A
SCHEMBL9994169 0.66 AKR1C3 (0.36) GPR119DGAT1KCNH2CYP2C9CYP3A4
SCHEMBL4888957 0.66 CHRM4 (0.39) ALDH1A1DGAT1KCNH2SMN1; SMN2KDM4E
SCHEMBL9994548 0.65 KDM4E (0.45) HPGDDGAT1KCNH2CYP2C9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889702-B2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof SANOFI (FR) 2014-11-18 US disclosed
US-20110319381-A1 DERIVATIVES OF AZASPIRANYL-ALKYLCARBAMATES OF 5-MEMBER HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319381-A1 DERIVATIVES OF AZASPIRANYL-ALKYLCARBAMATES OF 5-MEMBER HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF PRMT9, IDH3B, DHFR HSD17B10 822/4885HPGD 2223/4885ALDH1A1 532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.